Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol effects on driving performance in light and heavy cannabis users
NL-OMON33023Phase 4Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dronabinol in chronic pain, anorexia nervosa (AN), cachexia and 1 more (2 arms), sponsored by Maastricht University. Primary endpoint: Standard deviation of lateral position. Started Dec 2009; status: active, not recruiting.
02
Drugs
dronabinol
03
Conditions
chronic painanorexia nervosa (AN)cachexiachemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NL-OMON33023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33023.